Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression.

In major ischemic stroke patients, beta-blocker therapy did not lower post-stroke infection rates and was associated with urinary tract infections in a subgroup with insula/anterio-medial strokes.